Pfizer announces partnership with NIHR Clinical Research Network

Pfizer has announced a new collaboration with the National Institute for Health Research (NIHR) Clinical Research Network.

The partnership comes as part of Pfizer's s part of the company’s INSPIRE (Investigator Networks, Site Partnerships and Infrastructure for Research Excellence) programme, which is designed to improve access to innovation medicines and clinical trials.

Through INSPIRE, Pfizer and the NIHR Clinical Research Network will share expert knowledge and experience of medicines research, to help bring more clinical trials to the UK and deliver the best results for patients in the NHS.

Pfizer has selected the Greater Manchester Clinical Research Network to be part of the INSPIRE programme as a preferred location for its studies.

Freda Lewis-Hall, chief medical officer at Pfizer, said: "We are excited to be joining with the Clinical Research Network as part of our drive to bring a new wave of medicines and other treatments to patients in the UK and around the world."

In the UK today, Pfizer has 60 ongoing clinical trials across a range of therapeutic areas including oncology, cardiovascular, inflammation and neuroscience.